Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Heart Fail Clin. 2010 Jul;6(3):373-83. doi: 10.1016/j.hfc.2010.02.003. Epub 2010 May 13.

The economic burden of anemia in heart failure.

Author information

  • 1Haemonetics, 400 Wood Road, Braintree, MA 02164, USA. rkspence@ix.netcom.com

Abstract

Anemia is a complex issue in patients with heart failure (HF). In past years, clinicians accepted anemia as a given or an "accessory" diagnosis in HF patients. This attitude has changed since understanding of the causes and morbidity of anemia in HF has improved and with the introduction of targeted treatments. Increasing health care costs have stimulated vigorous debate about the cost-effectiveness of such treatments. It behooves clinicians to understand the effectiveness of specific treatments, risks and benefits, and costs. This review addresses the impact of anemia's prevalence, etiology, associated outcomes, and treatments on the economic burden of HF patients.

Copyright 2010 Elsevier Inc. All rights reserved.

PMID:
20630411
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk